Pseudomonas exotoxin a cd4+ t-cell epitopes

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/21 (2006.01) A61K 47/48 (2006.01) C07K 7/08 (2006.01)

Patent

CA 2622525

The present invention provides PE CD4+ T-cell epitopes, as well as novel variants that exhibit reduced immunogenic responses, as compared to the parental PE. The present invention further provides DNA molecules that encode novel PE variants, host cells comprising DNA encoding novel PE variants, as well as methods for making PEs less immunogenic. In addition, the present invention provides various compositions that comprise these PE variants that are less immunogenic than wild-type PEs.

La présente invention concerne des épitopes de cellules T CD4+ PE, de même que des variantes innovantes qui présentent des réponses immunogènes réduites par rapport à celles des PE parentaux. La présente invention concerne en outre des molécules d'ADN qui codent pour des variantes innovantes des PE, des cellules hôtes comprenant l'ADN qui code pour des variantes innovantes des PE, de même que des procédés permettant de rendre les PE moins immunogènes. De plus, La présente invention concerne diverses compositions qui comprennent ces variantes de PE moins immunogènes que les PE de type sauvage.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pseudomonas exotoxin a cd4+ t-cell epitopes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pseudomonas exotoxin a cd4+ t-cell epitopes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pseudomonas exotoxin a cd4+ t-cell epitopes will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2005356

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.